Will you help stop ovarian cancer before it starts?

Imagine a future where the next generation of women are protected from ovarian cancer before it ever has the chance to develop.

Right now, at the University of Oxford, Professor Ahmed and his team are working towards that future by developing what could be the world’s first vaccine to prevent ovarian cancer. It’s called OvarianVax.

This pioneering research aims to train the immune system to recognise and destroy cells that could develop into ovarian cancer, stopping the disease before it starts.

Now, their work has reached an important stage. The team has identified promising components for a future vaccine. The next challenge is working out how to deliver it safely and effectively into the body. It will take painstaking research, thousands of tests and many more hours in the lab to get there. And those hours depend on funding.

There is still a long way to go before a vaccine could become available. But the possibility of preventing this devastating disease offers something extraordinary - a future where fewer women have to endure invasive treatments, and fewer families lose someone they love far too soon.

Women with ovarian cancer are supporting Professor Ahmed’s critical work developing what could be the world’s first ovarian cancer vaccine. They know what ovarian cancer can do, and they’re united by a determination that other families don’t have to go through it too.